-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Et1WsRVC+ufM3FbpFHbKJOAaWTv5xvdBR83pM3u6ljJcjmCu/Dl5t8Ztc6/pmqF0 VyeEOkdas9B8UaWgdR3TPg== 0000889812-97-001880.txt : 19970912 0000889812-97-001880.hdr.sgml : 19970912 ACCESSION NUMBER: 0000889812-97-001880 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970910 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: MARK SOLUTIONS INC CENTRAL INDEX KEY: 0000807397 STANDARD INDUSTRIAL CLASSIFICATION: PREFABRICATED METAL BUILDINGS & COMPONENTS [3448] IRS NUMBER: 112864481 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-31601 FILM NUMBER: 97678016 BUSINESS ADDRESS: STREET 1: 1515 BROAD ST STREET 2: PARKWAY TECHNICAL CENTER CITY: BLOOMFIELD STATE: NJ ZIP: 07003 BUSINESS PHONE: 2013688118 MAIL ADDRESS: STREET 1: 1515 BROAD ST STREET 2: PARKWAY TECHNICAL CENTER CITY: BLOOMFIELD STATE: NJ ZIP: 07003 FORMER COMPANY: FORMER CONFORMED NAME: SHOWCASE COSMETICS INC DATE OF NAME CHANGE: 19920703 424B3 1 PROSPECTUS Rule 424(b)(3) File No. 333-31601 - ------------------------------------------------------------------------------- Prospectus MARK SOLUTIONS, INC. 1,782,500 Shares of Common Stock This Prospectus relates to the sale of up to 1,782,500 shares of common stock, $ .01 par value (the "Common Stock") of Mark Solutions, Inc. ("Mark") which are issuable upon conversion of Mark's $ 1,250,000 Principal Amount 7% Convertible Debentures (the "Debentures") or paid as interest on the Debentures. As of the date of this Prospectus, $ 1,250,000 principal amount of the Debentures remain outstanding. The Debentures were issued by Mark in a private placement in June 1997. The Debentures are convertible, in whole or in part, at the option of the holder, into shares of Common Stock at a conversion price of $ .80 per share. Interest is payable in cash or Common Stock, based on conversion formula stated above, at Mark's option. Mark is obligated to keep the registration statement (the "Registration Statement"), of which this Prospectus forms a part, effective until June 2, 1999. All of the shares of Common Stock offered hereby (the "Shares") are being sold for the account of and by the person(s) named under the caption "Selling Shareholders". Mark is bearing the cost related to the Registration Statement. The Selling Shareholders have advised Mark that the Shares may be sold by the Selling Shareholders or its pledgees, donees, transferees or other successors in interest from time to time in the open market or in privately negotiated transactions at prices satisfactory to the seller. See "Plan of Distribution". Mark will receive no proceeds from the sale of the Shares. THESE SECURITIES INVOLVE A HIGH DEGREE OF RISK. See "Risk Factors". The Common Stock is traded on NASDAQ Small Cap Market under the symbol "MCSI". On August 8, 1997, the closing sales price of the Common Stock was $ 2-7/16 per share. THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR BY ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. ------------------------------------------- The date of this Prospectus is August 8, 1997. 1 No person is authorized to give any information or to make any representations other than those contained in this Prospectus, and, if given or made, such information or representations should not be relied upon as having been authorized. This Prospectus does not constitute an offer to sell, or solicitation of an offer to purchase, the securities offered by this Prospectus, in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction. Neither the delivery of this Prospectus nor any distribution of the securities being offered pursuant to this Prospectus shall, under any circumstances, create an implication that there has been no change in the information set forth herein since the date of this Prospectus. AVAILABLE INFORMATION Mark has filed with the Commission a Registration Statement on Form S-3 (together with all amendments and exhibits thereto the "Registration Statement") under the Securities Act with respect to the Common Stock offered hereby. As permitted by the rules and regulations of the Commission, this Prospectus omits certain information contained in the Registration Statement. For such information, reference is made to the Registration Statement and the exhibits thereto. Mark is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance therewith Mark files reports and other information with the Commission. The Registration Statement, reports and other information filed by Mark with the Commission can be inspected and copied at the public reference facilities maintained by the Commission at Room 1024, 450 Fifth Street, N.W., Washington, D.C. 20549, and at the Commission's Regional Offices at 7 World Trade Center, Suite 1300, New York, New York 10048, 1401 Brickell Avenue, Suite 200, Miami, Florida 33131, 500 West Madison Street, Suite 1400, Chicago, Illinois 60661, 1801 California Street, Suite 4800, Denver Colorado 80202 and 5670 Wilshire Boulevard, 11th Floor, Los Angeles, California 90036. Copies of such material also can be obtained from the Public Reference Section of the Commission, Washington, D.C. 20549 at prescribed rates. In addition, the Commission maintains an internet site (http:// www.sec.gov) that contains reports, proxy statements and other information regarding Mark, which is an electronic filer under Regulation S-T. 2 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE The following documents previously filed by Mark (Commission File No. 0-17118) with the Commission pursuant to the Exchange Act are incorporated and made a part of this Prospectus by reference: (1) Mark's Annual Report on Form 10-K for the year ended June 30, 1996, as amended; (2) Mark's Quarterly Report on Form 10-Q for the period ended September 30, 1996; (3) Mark's Quarterly Report on Form 10-Q for the period ended December 31, 1996, as amended; (4) Mark's Quarterly Report on Form 10-Q for the period ended March 31, 1997, as amended; (5) Mark's Current Report on Form 8-K dated May 28, 1996 as amended; (6) The description of the Common Stock contained in the Registration Statement on Form 8-A. All documents filed by Mark pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this Prospectus and prior to the termination of the offering contemplated by his Prospectus shall be deemed to be incorporated by reference into this Prospectus and to be a part hereof from the date of filing such documents. Any statements contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Prospectus to the extent that a statement contained herein or in any subsequently filed documents which also is or is deemed to be incorporated by reference herein modified or supersedes such earlier statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Prospectus. Mark undertakes to provide without charge to each person, including any beneficial owner, to whom a copy of this Prospectus has been delivered, on written or oral request of any such person, a copy of any or all of the documents referred to above which have been or may be incorporated by reference in the Prospectus, other than exhibits to such documents (unless such documents are specifically incorporated by reference in such documents). Requests for such copies should be directed to Ms. Cheryl Gomes, Mark Solutions, Inc., 1515 Broad Street, Bloomfield, New Jersey 07003, Telephone Number (201) 893-0500. 3 TABLE OF CONTENTS Page Available Information . . . . . . . . . . . . . . . . . . 2 Incorporation of Certain Documents by Reference . . . . . 3 The Company . . . . . . . . . . . . . . . . . . . . . . . 5 Summary Selected Financial Data . . . . . . . . . . . . . 6 Risk Factors. . . . . . . . . . . . . . . . . . . . . . . 7 Selling Shareholders . . . . . . . . . . . . . . . . . . 11 Plan of Distribution . . . . . . . . . . . . . . . . . . 11 Legal Matters . . . . . . . . . . . . . . . . . . . . . . 12 Experts . . . . . . . . . . . . . . . . . . . . . . . . . 12 4 THE COMPANY Mark Solutions, Inc. ("Mark") is a Delaware corporation which operates its various businesses through wholly-owned subsidiaries and a division. Mark is engaged in the design, manufacture and/or installation of (i) modular steel cells for housing of the general prison population as well as for use as infectious disease isolation units for correctional institutions and health care facilities, (ii) a treatment booth for communicable diseases and (iii) diagnostic support and archiving computer systems marketed under the name "IntraScan". In its marketing of modular steel products, Mark responds to public bids and pursues joint ventures and affiliations with other companies to solicit design, build and/or operate correctional facilities projects both domestically and internationally. Mark's modular cells meet or exceed all applicable building and safety code requirements in the United States and can be manufactured and installed more efficiently than traditional housing alternatives by virtue of lower labor and construction costs and shorter installation time. Management also believes that its prefabricated modular cell manufacturing process has other applications such as temporary emergency housing and permanent shelters, although no assurances can be given that such applications will be successfully developed and marketed. Management believes that continued nationwide judicial and legislative emphasis on an expedient easing of the overcrowding conditions of correctional institutions, as well as the increase in the demand for isolation and treatment quarters for both correctional institutions and healthcare facilities, due to the rise in communicable diseases such as tuberculosis and the HIV virus, present a significant growth opportunity for Mark. However, there can be no assurance that any such business will develop. Mark was incorporated under the laws of the State of Delaware on September 29, 1986 under the name "Showcase Cosmetics, Inc." Mark's principal executive office is located at Parkway Technical Center, 1515 Broad Street, Bloomfield, New Jersey 07003 and its telephone number is (201) 893-0500. 5 SUMMARY SELECTED FINANCIAL DATA The following summary selected financial data is based upon financial information incorporated herein and such summary information should be read in conjunction with such financial statements and notes thereto. Income Statement Data: Nine Months Ended March 31 Fiscal Years Ended June 30 ----------------------- ----------------------------------- 1997 1996 1996 1995 1994 ----------------------- ----------------------------------- Revenues $3,276,578 $3,206,371 $3,454,615 $6,125,573 $3,183,073 Cost and Expenses 5,564,803 8,518,483 8,518,483 9,852,303 6,233,374 (Loss) From Continuing Operations (2,998,801) (3,306,705) (5,110,559) (3,812,635) (3,144,510) (Loss) From Discontinued Operations -- ( 104,503) ( 104,503) (1,377,438) ( 993,620) Net income (Loss) (2,998,801) (3,411,208) (5,215,062) (5,190,073) (4,138,130) Earnings (Loss) per Share ( $ .21) ( $ .27) ( $ .41) ( $ .48) ( $ .47) Weighted Average Shares Outstanding 13,974,665 12,500,250 12,732,022 10,726,204 8,802,543 Balance Sheet Data: At June 30 At March 31 ------------------------------------ 1997 1996 1995 1994 ---------- ------------------------------------ Working Capital (Deficit) $1,362,231 $ 675,864 ($ 48,112) $ 216,635 Total Assets 4,839,033 3,083,763 3,978,383 4,953,651 Long-term Obligations 1,739,343 50,297 19,665 8,313 Total Liabilities 3,787,126 1,004,362 2,189,322 918,006 Stockholders' Equity 1,051,907 2,079,401 1,789,061 4,035,645 6 RISK FACTORS Prospective investors in the Common Stock should give careful consideration to the following risks in making a decision concerning the securities offered hereby. 1. Poor Financial Condition. Mark has experienced significant operating losses and working capital and liquidity deficiencies over the past several years. Mark had net losses of $ 5,215,062 and $ 5,190,073 for the fiscal years ended June 30, 1996 and 1995. In addition, Mark had an accumulated deficit of $ 22,316,660 at June 30, 1996. Mark has and will continue to experience such financial difficulties in the foreseeable future absent significant increases in the sale of modular cells, its principal product. Accordingly, based on past operating results there can be no assurance that Mark will be able to operate profitably. Mark's poor financial condition could adversely effect its ability to raise additional working capital pursuant to private sales of its securities. 2. Limited Market; Contracts for Modular Cells. Mark has derived substantially all of its revenue from the sale of its modular cells and disease containment units to correctional institutions and management believes that the sale of these products will continue to represent the substantial majority of Mark's operating revenues through December 31, 1997. The correctional institution market presents substantial sales obstacles. Unless the project is very small, correctional institutions, like other government agencies, must submit proposed projects to public bidding by prospective suppliers. The purchasing agency is obligated to select from among the bidders based on objective criteria. On the other hand, private purchasers generally do not require bidding and a vendor such as Mark would have the opportunity to convince the purchaser to deal with Mark to the exclusion of competitors. Mark continually bids on and solicits joint venture opportunities regarding construction projects utilizing its modular steel cell products. At present, Mark is not participating in any projects under a joint venture format. Mark currently has contracts for it modular cells aggregating approximately $ 4,300,000 in revenue for the period beginning January 1, 1997 to August 31, 1997. 3. Working Capital Requirements. The ultimate success of Mark may depend upon its ability to raise additional equity or obtain debt financing until it can improve its operating results. To date Mark has primarily met its working capital requirements by 7 the private issuance of its securities, including the Debentures. Absent proceeds from the exercise of outstanding warrants and improvement in the operations of Mark, management believes that its present available working capital will be utilized by July 31, 1997. In the event Mark must seek other sources of working capital, it will most likely have to rely on additional private sales of its equity or debt securities. While Mark has been successful in raising working capital through private sources in the past, no assurance can be given that such sources will be available, or, if available, on terms satisfactory to Mark. Mark will initially look to the exercise of outstanding warrants to the extent that additional working capital is necessary. 4. Significant Contract. Effective March 15, 1996, Mark received a three-year contract for modular cells from the State of New York. Management anticipates that this contract will generate revenues of approximately $ 50,000,000 over the three years ending December 31, 1999, which would represent Mark's largest contract to date. The agreement has a stated estimate of 2,455 cells, however no minimum volume is guaranteed. In addition, the State of New York reserves the right to renegotiate the stated contract prices or solicit third party bids for any single order of 700 or more cells. Accordingly, no assurances can be given that Mark will realize the revenues estimated by management. 5. Competition. The construction industry in general and the government construction industry in particular are highly competitive. Due to the use of concrete and other traditional construction methods in the substantial majority (approximately 90%) of correctional facility construction, Mark competes for market share with a number of major construction companies. Such competition is not with respect to any particular project, but in efforts to convince the purchasing agency to utilize steel cell construction rather than traditional methods. With respect to those projects which incorporate modular steel cell specifications in its design criteria, other companies are beginning to enter the field. Some of these companies have greater financial resources than Mark. In addition, a number of manufacturers which have greater financial and marketing resources than Mark, and which currently produce sheet metal products, could ultimately enter the modular cell business in competition with Mark. Accordingly, there can be no assurance that Mark will be able to successfully compete in the market for modular steel cells, which are Mark's most significant product. 6. Dependence on Key Person. Mark is dependent upon the continued services of Carl C. Coppola, its Chairman of the Board, President and Chief Executive Officer. The loss of Mr. Coppola could have a material adverse effect on Mark. Mark is the 8 beneficiary of a term life insurance policy of $1,000,000 on the life of Mr. Coppola. 7. Bonding Qualifications. In connection with some government construction projects, Mark is required to provide performance and completion bonds as a condition to submission or participation in a bid. Due to Mark's financial condition, it has generally been unable to obtain bonds without the assistance and guarantee of third parties, including Mark's president and or another business entity owned by an outside director. To date Mark has not limited its bidding activity nor lost any projects due to its limited bonding capacity. However, as Mark is awarded multiple projects, the inability to obtain bonds may limit the number of additional projects Mark can pursue and have a material adverse effect on the operations of Mark. 8. Recent Trading Prices; Nasdaq Listing Maintenance Requirements. From February 27, 1997 to June 20, 1997, Mark's Common Stock traded below $ 2.00 per share, including trades at below $ 1.00 per share. On August 8, 1997 the closing sales price of the Common Stock was $ 2-7/16 per share. Mark's Common Stock trades on the Nasdaq Small Cap Market tier of the Nasdaq Stock Market. To be eligible for continued listing of its Common Stock, Mark is required to maintain a bid price of $ 1.00 per share. If Mark fails to maintain its Nasdaq Small Cap Market listing, the liquidity of the Common Stock would be adversely affected. In addition, Mark's ability to raise additional working capital through sales of its equity securities would also be adversely affected. 9. Potential Application of Exchange Act "Penny Stock" Rules. In the event Mark fails to maintain its Nasdaq Small Cap Market listing due to the failure to meet the minimum bid price requirements, Mark's Common Stock could be a "penny stock" as that term is defined in the Exchange Act. Brokers effecting transactions in a "penny stock" are subject to additional customer disclosure and record keeping obligations including disclosure of the risks associated with low price stocks, stock quote information and broker compensation. In addition, brokers effecting transactions in a "penny stock" are also subject to addition sales practice requirements under Rule 15g-9 of the Exchange Act including making inquiries into the suitability of "penny stock" investments for each customer or obtaining a prior written agreement for the specific "penny stock" purchase. Because of these additional obligations, certain brokers will not effect transactions in "penny stocks", which could have an adverse effect on the liquidity of the security and make selling it more difficult. 9 10. Impact of Conversion Price of Debentures on Trading Prices of Common Stock. Due to the right of the holder to convert the Debentures into shares of Common Stock at the discounted rate of $ .80 per share, rises in the trading price of the Common Stock may met resistance due to the potential sale of the underlying Common Stock which reflect the reduced purchase price resulting from the conversion rate. On January 21, 1997, Mark issued additional convertible debentures in the principal amount of $ 750,000 which provide for a conversion rate of the average bid price of the five trading days prior to the date of conversion. On June 30, 1997 Mark issued additional convertible debentures in the principal amount of $300,000 which may be converted into shares of Common Stock at $ .80 per share. These debentures may similarly affect the trading price of the Common Stock. 11. Subcontractor Credit Risk. Mark's manufacturing operations are limited to the steel modular cell for use as one component of correctional institution projects. Therefore, Mark may not be the prime contractor on a project, but a subcontractor. Under these circumstances, Mark usually will not have the direct financial obligation of the government agency or other purchaser, but will be primarily relying on the prime contractor regarding payment for its products. This presents a greater credit risk to Mark. 12. Related Party Transactions. Mark has been a party to business transactions with certain officers, Directors or their affiliates. Mark intends to purchase goods and services in the ordinary course of business from related parties and may determine based upon circumstances at that time to engage in additional transactions with officers, Directors, principal shareholders or affiliates. While Mark believes these transactions have been on terms no less favorable than could be obtained from unaffiliated parties, such situations present potential conflicts of interest. 13. No Dividends. Mark has never paid a cash dividend on its Common Stock. Mark does not intend to pay in the foreseeable future, cash dividends on the Common Stock but intends to retain its earnings to finance growth. 10 SELLING SHAREHOLDERS The 1,782,500 shares of Common Stock offered hereby are being offered for the account of the following person(s). The information regarding such person(s) and beneficial ownership of Common Stock has been provided by the Selling Shareholders. Shares of Shares of Common Stock Shares of Common Stock Beneficially Common Stock Owned After Owned(1)(2) Offered Offering(1)(2) ------------ ------------- -------------- Name - ------------------- Marquise LLC 1,562,500 1,562,500 0 - ---------- (1) Assumes payment of interest on Debentures in cash and conversion of the entire principal amount of Debentures at the conversion price of $ .80 per share. (2) Excludes 150,000 shares of Common Stock beneficially owned by members of Marquise LLC or affiliated investment companies. PLAN OF DISTRIBUTION The sale of shares of Common Stock by the Selling Shareholders may be effected from time to time in transactions on one or more exchanges or in the over-the-counter market, or otherwise in negotiated transactions, through the timing of options on the shares or through a combination of such methods of sale, at fixed prices, which may be charged at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. The Selling Shareholders may effect such transactions by selling the shares of Common Stock in an exchange distribution in accordance with the rules of such exchange to or through broker-dealers, and such broker-dealers may receive compensation in the form of discounts, concessions or commissions from the Selling Shareholders and/or the purchasers of the shares of Common Stock for which such broker-dealer may act as agent or to whom they sell as principal, or both (which compensation as to a particular broker-dealer may be in excess of customary compensation). The Selling Shareholders and any broker-dealers who act in connection with the sale of the shares of Common Stock hereunder may be deemed to be "underwriters" within the meaning of Section 2(11) of the Securities Act, and any commissions received by them and profit on any sale of the shares of Common Stock as principal might be deemed to be underwriting discounts and commissions under the Securities Act. 11 In addition any securities covered by the Prospectus which qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to the Prospectus, as supplemented. From time to time the Selling Shareholders may engage in short sales, short sales against the box, puts and calls and other transactions in securities of Mark or derivatives thereof, and may sell and deliver the shares in connection therewith. From time to time Selling Shareholders may pledge their shares pursuant to the margin provisions of their respective customer agreements with their respective brokers. Upon a default by a Selling Shareholder, the broker may offer and sell the pledged shares of the Common Stock from time to time. LEGAL MATTERS Timothy J. McCartney, Esq. has acted as counsel for Mark and has rendered an opinion on the validity of the shares of Common Stock to be issued upon conversion of the Debentures. EXPERTS Mark's consolidated balance sheets as of June 30, 1996 and 1995 and the consolidated statements of operations, stockholders' equity and cash flows for each of the three years in the period ended June 30, 1996 incorporated by reference in this Prospectus, have been incorporated herein in reliance on the report of Sax Macy Fromm & Co., P.C., independent certified public accountants, given on the authority of that firm as experts in accounting and auditing. 12 -----END PRIVACY-ENHANCED MESSAGE-----